Interestingly, our study of human melanoma A375P cells reveals that AT-9283 disrupts the G1-to-S-phase transition by inhibiting Rb1 protein phosphorylation, resulting in a significant decrease in the G2/M and S populations of the cell cycle (Figure 2). Here, RB1 is linked to melanoma.